RetroVirox's Grant

RetroVirox raised a round of funding on March 12, 2015. Investors include National Institutes of Health.

RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases. The company offers its discovery platforms and antiviral services to…

Articles about RetroVirox's Grant: